This is the text extract for 2010-08 Schedule Dispatch, browse documents here.

16 July 2010 August 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the August 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings · Hydrocortisone with cinchocaine (Proctosedyl) oint (p’code 208388) and suppos (p’code 208396) · Insulin glulisine inj 100 u per ml, 10 ml (Apidra) (p’code 2317109) and inj 100 u per ml, 3 ml disposable pen (Apidra SoloStar) (p’code 2316870) · Danthron with poloxamer (Pinorax Forte) oral liq 75 mg with poloxamer 1 g per 5 ml only on a prescription – only for the prevention or treatment of constipation in the terminally ill (p’code 2259443) · Sodium citrate with sodium lauryl sulphoacetate (Micolette) enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml – Only on a prescription (p’code 2262673) · Ascorbic acid (Vitala-C) tab 100 mg – no more than 100 mg per dose, only on a prescription (p’code 2360853) · Terazosin hydrochloride (Arrow) tab 1 mg (p’code 2354306) , 2 mg (p’code 2354314) and 5 mg (p’code 2354292) · Amiloride with hydrochlorothiazide (Moduretic) tab 5 mg with hydrochlorothiazide 50 mg – Section 29 (p’code 2364433) · Indapamide (Dapa-Tabs) tab 2.5 mg (p’code 2356406) · Triclosan (healthE) soln 1 % - maximum of 500 ml per prescription, subsidy by endorsment (p’code: 2360128) · Malathion (A-Lices) liq 0.5 % (p’code 2090902) · Levonorgestrel (Jadelle) subdermal implant (2 x 75 mg rods) (p’code 2265532) · Tamsulosin hydrochloride (Tamsulosin-Rex) cap 400 µg – Special Authority – Retail pharmacy (p’code 2220512) · Ceftriaxone sodium (Aspen Ceftriaxone) inj 1 g – subsidy by endorsement (p’code 2364425) · Quetiapine (Dr Reddy’s Quetiapine) tab 25 mg (p’code 2363283), 100 mg (p’code 2363291), 200 mg (p’code 2363305) and 300 mg (p’code 2363313) · Risperidone (Dr Reddy’s Risperidone) tab 0.5 mg (p’code 2356546) · Azathioprine (Imuprine) tab 50 mg – Retail pharmacy – Specialist (p’code 2358735) · Ipratropium bromide (Univent) nebuliser soln, 250 µg per ml, 1 ml (p’code 2154293) and nebuliser soln, 250 µg per ml, 2 ml (p’code 2154307) – available on a PSO Changes to restrictions · Insulin glargine inj 100 u per ml, 10 ml and 3 ml (Lantus), and 3 ml disposable pen (Lantus Solostar) – removal of Special Authority criteria and addition of prescribing note · Ketone blood beta-ketone electrodes (Optium Blood Ketone Test Strips) test strip – removal of endorsement criteria and addition of maximum rule · Sodium nitroprusside (Ketostix) test strip – addition of maximum rule · All Hospital pharmacy [HP1] medicines – removal of Hospital Pharmacy [HP1] restriction · Hospital pharmacy [HP1]-Specialist – replaced with Retail pharmacy-Specialist · Hospital pharmacy [HP3] medicines except Special Foods – removal of Hospital pharmacy [HP3] restriction · Hospital pharmacy [HP3]-Specialist – replaced with Retail pharmacy-Specialist · WSO restriction – removal of WSO restriction and transfer to ‘Only on a PSO’ · Furosemide (Urex Forte) tab 500 mg – removal of Section 29 · Diaphragm (Ortho All-flex and Ortho Coil) amended presentation descriptions A368621 Page 1 of 2

· · · · ·

Cabergoline (Dostinex and Arrow-Cabergoline) tab 0.5 mg – amended Special Authority criteria Tenofovir disoproxil fumarate (Viread) tab 300 mg – amendment subsidy restriction Antiretrovirals – amendment of Special Authority criteria Adalimumab inj 40 mg per 0.8 ml prefilled pen (Humira) and syringe (HumiraPen) – amended Special Authority criteria Exemestane (Aromasin) tab 25 mg – removal of repeat rule

Decreased subsidy

Chemical Presentation Fully brands subsidised Partially subsidised brands

Ketone blood beta-ketone electrodes Calcium carbonate Enalapril

Test strip, 10 strip OP Tab 1.25 g (500 mg elemental) Tab 1.5 g (600 mg elemental) Tab 5 mg Tab 10 mg Tab 20 mg Tab 5 mg with hydrochlorothiazide 12.5 mg Tab 500 mg Tab 5 mg Inj 8 million iu per 1 ml Inj 1 mg for ECP Inj 100 mg intrathecal syringe for ECP Inj 20 mg per ml, 2 ml Inj 20 mg per ml, 5 ml Inj 1 mg for ECP

Optium Blood Ketone Test Strips Calci-Tab 500 Calci-Tab 600 m-Enalapril*, ArrowEnalapril Arrow-Enalapril Arrow-Enalapril Inhibace Plus Urex Forte Methatabs Betaferon Baxter

m-Enalapril m-Enalapril

Cilazapril with hydrochlorothiazide Furosemide Methadone hydrochloride Interferon beta-1 beta Cytarabine

Irinotecan

Camptosar Camptosar Baxter

* only the 5 mg presentation of m-Enalapril will be fully funded from 1 August 2010. All presentations of m-Enalapril will be delisted from 1 November 2010 Increased subsidy

Chemical Imiglucerase Amiloride with frusemide Povidone iodine Azathioprine Food thickener Presentation Inj 40 iu per ml, 200 iu vial Tab 5 mg with frusemide 40 mg Oint 10 %, 25 g OP Inj 50 mg Powder 380 g OP Fully brands subsidised

Cerezyme Frumil Betadine Imuran Karicare Food Thickener

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule from the 20th of July 2010.

Note: PHARMAC will issue another fax communication to pharmacy regarding changes to occur in the Pharmaceutical Schedule next Tuesday 20th July 2010.

A368621 Page 2 of 2